tyrosine has been researched along with Diabetic Cardiomyopathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Geng, G; Han, W; Hao, Y; Hao, Z; Jia, K; Liu, H; Liu, L; Liu, Y; Wang, D; Zhou, Y | 1 |
| Li, H; Tian, MM; Wang, YY; Yan, XL; Yu, ZF | 1 |
| Guo, Z; Li, J; Man, F; Pan, Q; Wang, H; Wang, W; Xu, J; Yan, W; Zhou, Y | 1 |
| Wei, JR; Zhang, YL | 1 |
| Bauer, JA; Cook, AC; Joshi, MS; Mihm, MJ; Schanbacher, BL | 1 |
| Hou, R; Lau, WB; Liu, S; Tao, L; Wang, H; Yin, T | 1 |
| Fujita, M; Iwasaka, T; Jo, F; Jo, H; Kosaki, A; Okazaki, T; Otani, H; Shimazu, T; Yoshioka, K | 1 |
1 trial(s) available for tyrosine and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study.
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Diabetic Cardiomyopathies; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Safety; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
6 other study(ies) available for tyrosine and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma activation attenuates diabetic cardiomyopathy via regulation of the TGF-β/ERK pathway and epithelial-to-mesenchymal transition.
Topics: Animals; Benzophenones; Diabetic Cardiomyopathies; Epithelial-Mesenchymal Transition; Fibrosis; Inflammation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Myocardium; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Signal Transduction; Transforming Growth Factor beta; Tyrosine | 2018 |
Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats.
Topics: Animals; Autophagy; Beclin-1; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Humans; Lipids; Male; Myocytes, Cardiac; Nitrosative Stress; Obesity; Rats, Zucker; Sitagliptin Phosphate; Stroke Volume; Tyrosine; Ventricular Function, Left | 2018 |
3-nitrotyrosine, a biomarker for cardiomyocyte apoptosis induced by diabetic cardiomyopathy in a rat model.
Topics: Animals; Apoptosis; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Tetrazoles; Tyrosine; Valine; Valsartan | 2013 |
Alterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation.
Topics: Animals; Blotting, Western; Connexin 43; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Electrophysiology; Hyperglycemia; Immunoenzyme Techniques; Immunoprecipitation; Male; Nitrogen; Oxidative Stress; Phosphorylation; Rats; Rats, Sprague-Dawley; Tyrosine | 2015 |
Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury.
Topics: Animals; Apoptosis; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Heart; Hyperglycemia; Immunoblotting; Immunoprecipitation; Mice; Myocardial Reperfusion Injury; Nitrates; Nitrosation; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Thioredoxins; Tyrosine | 2010 |
Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
Topics: Animals; Biopterins; Cardiotonic Agents; Coenzymes; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enzyme Inhibitors; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Pterins; Tyrosine; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |